CD4 and melanoma: Overall, in comparison to healthy controls, melanoma patients demonstrated reduced numbers of CD4 and CD8 naive T cells coupled with indications of memory T‐cell activation denoted by increased Ki67 and IL‐2 positivity and a skewed γδT‐cell phenotype.